Evidence map›Paper›PMID 42157819›Full record

ArticleACS medicinal chemistry letters2026

DEL2PH4: Predictive 3D Pharmacophores from DNA-Encoded Library Screening Data.

Miklos Feher, Rebecca J Swett, Ryan T Walsh, Erin Davis, Christopher I Williams

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miklos FeherX-Chem Inc., 4800 Rue Levy, Suite 200, Montreal, QC H4R 2P7, Canada.ORCID https://orcid.org/0009-0004-9618-2482
Rebecca J SwettX-Chem Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02453, United States.
Ryan T WalshX-Chem Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02453, United States.
Erin DavisX-Chem Inc., 100 Beaver Street, Suite 101, Waltham, Massachusetts 02453, United States.
Christopher I WilliamsChemical Computing Group, Suite 910, 1010 Sherbrooke Street West, Montreal, QC H3A 2R7, Canada.ORCID https://orcid.org/0000-0001-5428-2742

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA-encoded library (DEL) screening enables identification of small-molecule binders from libraries containing billions of compounds, yet much of the resulting structure-activity relationship (SAR) information remains underutilized. Here, we describe DEL2PH4, an automated ligand-based workflow that converts DEL screening data into three-dimensional pharmacophore models by integrating statistically enriched compounds with structurally related unenriched analogs, which serve as negative examples during model construction. The resulting pharmacophores capture consensus interaction features across DEL families and enable the extraction of actionable 3D SAR information from primary DEL screening data, independent of resynthesis or activity measurements. Application to a MerTK kinase DEL screen demonstrates strong enrichment of positives over decoy molecules in retrospective benchmarking, recovery of known experimentally validated actives from external data sets, and consistency with experimentally determined X-ray binding modes. DEL2PH4 provides a general strategy for translating DEL screening outputs into interpretable 3D models that support virtual screening, scaffold hopping, and medicinal chemistry optimization.

Indexed as

Computational drug discoveryDNA-encoded librariesHit discoveryLigand-based modelingMerTK kinasePharmacophore modelingStructure−activity relationshipsVirtual screening

Identifiers

PMID42157819
PMCPMC13181497

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.